Abstract

The Protein Kinase D (PKD) isoforms PKD1, PKD2, and PKD3 are effectors of the novel Protein Kinase Cs (nPKCs) and diacylglycerol (DAG). PKDs impact diverse biological processes like protein transport, cell migration, proliferation, epithelial to mesenchymal transition (EMT) and apoptosis. PKDs however, have distinct effects on these functions. While PKD1 blocks EMT and cell migration, PKD2 and PKD3 tend to drive both processes. Given the importance of EMT and cell migration to the initiation and progression of various malignancies, abnormal expression of PKDs has been reported in multiple types of cancers, including breast, pancreatic and prostate cancer. In this review, we discuss how EMT and cell migration are regulated by PKD isoforms and the significance of this regulation in the context of cancer development.

Highlights

  • Protein Kinase D family members are serine/threonine kinases that function downstream of the novel Protein Kinase Cs and diacylglycerol

  • There is a growing body of evidence which shows that Protein Kinase D (PKD) family members are key regulators of epithelial to mesenchymal transition (EMT) and cell migration

  • It is well-established that PKD1 through the phosphorylation of Snail and other regulatory molecules contributes to the maintenance of the epithelial phenotype and blocks cell migration

Read more

Summary

Introduction

Protein Kinase D family members are serine/threonine kinases that function downstream of the novel Protein Kinase Cs and diacylglycerol. PKD activation has been shown to occur in response to oxidative stress [10,11,12], binding of G beta-gamma (Gβγ) proteins to the PKD family PH domain at the Golgi [13], as well as caspase 3-mediated proteolytic cleavage [14]. Even though aforementioned demonstrate that PKD isoforms, dependent on the signaling pathway, family members have similar modular structures, they doPKD exhibit some structural variability. PKD1 is highly-expressed in ductal epithelial cells of the normal breast while its expression is downregulated in highly‐invasive breast cancers [29,49]. We discuss how PKD isoforms contribute to EMT and cell migration, two biological processes relevant for tumor development and progression.

EMT and Cell Migration
PKD1 Maintains the Epithelial Phenotype and Inhibits Cell Migration
PKD1 in Cancer
Contribution of PKD2 and PKD3 to EMT and Cell Migration
PKD as a Potential Therapeutic Target
Findings
Summary and Perspectives

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.